At the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, Hélio Tomás, PhD, senior research associate at the Instituto de Biologia Experimental e ...
The company is establishing commercial production capabilities to fuel plans to launch autologous CAR-T cell therapies in China.
Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.
ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
Pharmaceutical Technology on MSN
Quintessence debuts first ‘living’ artificial cell for CGT bio-separation
The technology is designed to simplify the bio-separation process while reducing manufacturing costs.
Sartorius has collaborated with ElevateBio, a cell therapy CDMO, among other partners, to test the Eveo platform.
Eveo Cell Therapy Platform enables automated, multi-parallel intensified production of autologous cell therapies Compact design can increase output up to fourfold in existing cleanroom space 90 ...
What is the current status of cell therapies today? It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the ...
LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...
Have you ever asked how doctors help the body repair itself when a serious disease damages cells or tissues? Modern medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results